Ginsenoside Re attenuates ferroptosis induced by hepatic ischemia-reperfusion injury via the BAP1/SLC7A11 axis.
Hepatic ischemia-reperfusion injury (HIRI) is a complex clinical complication involving inflammation and multiple forms of regulated cell death, among which ferroptosis plays a critical role. Ginsenoside Re (Re) exhibits prominent antioxidant capabilities, but its exact molecular targets in HIRI are unidentified. Here,...